Solid Tumor Testing Market Size, Trends, Analysis, and Outlook By Type (Genetic Testing, Conventional Testing), By Application (Prostate, Breast, Colorectal, Endometrial, Lung, Melanoma, Brain, Thyroid, Liver, Ovarian, Others), By End-user (Pharmaceutical and Biotechnology Companies, Hospitals, Contract Research Organizations, Academic Research Institutions), by Region, Country, Segment, and Companies, 2024-2030
The global Solid Tumor Testing market size is poised to register 7.7% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Solid Tumor Testing market across By Type (Genetic Testing, Conventional Testing), By Application (Prostate, Breast, Colorectal, Endometrial, Lung, Melanoma, Brain, Thyroid, Liver, Ovarian, Others), By End-user (Pharmaceutical and Biotechnology Companies, Hospitals, Contract Research Organizations, Academic Research Institutions).
The Solid Tumor Testing market is experiencing rapid growth, driven by advances in molecular diagnostics, personalized medicine approaches, and the increasing prevalence of cancer worldwide. Solid tumor testing, which involves analyzing tumor tissue or circulating biomarkers to identify genetic mutations, protein expression patterns, and other molecular characteristics, plays a critical role in guiding cancer treatment decisions and optimizing patient outcomes. With factors such as rising cancer incidence, growing demand for targeted therapies, and the need for comprehensive genomic profiling driving the market, diagnostic laboratories, biotechnology companies, and academic institutions are investing in next-generation sequencing platforms, multiplex assays, and bioinformatics tools for solid tumor testing. With ongoing research into tumor heterogeneity, drug resistance mechanisms, and immune evasion pathways, the market for solid tumor testing is poised for further expansion, offering hope for more effective and personalized cancer treatments.
Solid Tumor Testing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Solid Tumor Testing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Solid Tumor Testing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Solid Tumor Testing industry.
Key market trends defining the global Solid Tumor Testing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Solid Tumor Testing Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Solid Tumor Testing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Solid Tumor Testing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Solid Tumor Testing industry
Leading Solid Tumor Testing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Solid Tumor Testing companies.
Solid Tumor Testing Market Study- Strategic Analysis Review
The Solid Tumor Testing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Solid Tumor Testing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Solid Tumor Testing Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Solid Tumor Testing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Solid Tumor Testing market segments. Similarly, Strong end-user demand is encouraging Canadian Solid Tumor Testing companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Solid Tumor Testing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Solid Tumor Testing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Solid Tumor Testing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Solid Tumor Testing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Solid Tumor Testing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Solid Tumor Testing in Asia Pacific. In particular, China, India, and South East Asian Solid Tumor Testing markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Solid Tumor Testing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Solid Tumor Testing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Solid Tumor Testing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Solid Tumor Testing.
Solid Tumor Testing Market Company Profiles
The global Solid Tumor Testing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, Agilent Technologies Inc, AMSBIO, Biocare Medical LLC, BioLifeSolutions Inc, CellGenix GmbH., Corning Inc, F. Hoffmann-La Roche AG, Illumina Inc, LGC SeraCare, MedGenome Labs Private Ltd, Myriad Genetics Inc, Princeton CryoTech, QIAGEN, Quest Diagnostics Inc, STEMCELL Technologies Inc, Thermo Fisher Scientific Inc
Recent Solid Tumor Testing Market Developments
The global Solid Tumor Testing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Solid Tumor Testing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
Genetic Testing
-Next generation sequencing
-Real-time PCR
-Fluorescent In-Situ Hybridization
-Fragment Analysis
Conventional Testing
By Application
Prostate
Breast
Colorectal
Endometrial
Lung
Melanoma
Brain
Thyroid
Liver
Ovarian
Others
By End-User
Pharmaceutical and Biotechnology Companies
Hospitals
Contract Research Organizations
Academic Research Institutions
Geographical Segmentation:
Abbott Laboratories
Agilent Technologies Inc
AMSBIO
Biocare Medical LLC
BioLifeSolutions Inc
CellGenix GmbH.
Corning Inc
F. Hoffmann-La Roche AG
Illumina Inc
LGC SeraCare
MedGenome Labs Private Ltd
Myriad Genetics Inc
Princeton CryoTech
QIAGEN
Quest Diagnostics Inc
STEMCELL Technologies Inc
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
The Solid Tumor Testing market is experiencing rapid growth, driven by advances in molecular diagnostics, personalized medicine approaches, and the increasing prevalence of cancer worldwide. Solid tumor testing, which involves analyzing tumor tissue or circulating biomarkers to identify genetic mutations, protein expression patterns, and other molecular characteristics, plays a critical role in guiding cancer treatment decisions and optimizing patient outcomes. With factors such as rising cancer incidence, growing demand for targeted therapies, and the need for comprehensive genomic profiling driving the market, diagnostic laboratories, biotechnology companies, and academic institutions are investing in next-generation sequencing platforms, multiplex assays, and bioinformatics tools for solid tumor testing. With ongoing research into tumor heterogeneity, drug resistance mechanisms, and immune evasion pathways, the market for solid tumor testing is poised for further expansion, offering hope for more effective and personalized cancer treatments.
Solid Tumor Testing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Solid Tumor Testing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Solid Tumor Testing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Solid Tumor Testing industry.
Key market trends defining the global Solid Tumor Testing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Solid Tumor Testing Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Solid Tumor Testing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Solid Tumor Testing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Solid Tumor Testing industry
Leading Solid Tumor Testing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Solid Tumor Testing companies.
Solid Tumor Testing Market Study- Strategic Analysis Review
The Solid Tumor Testing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Solid Tumor Testing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Solid Tumor Testing Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Solid Tumor Testing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Solid Tumor Testing market segments. Similarly, Strong end-user demand is encouraging Canadian Solid Tumor Testing companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Solid Tumor Testing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Solid Tumor Testing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Solid Tumor Testing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Solid Tumor Testing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Solid Tumor Testing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Solid Tumor Testing in Asia Pacific. In particular, China, India, and South East Asian Solid Tumor Testing markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Solid Tumor Testing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Solid Tumor Testing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Solid Tumor Testing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Solid Tumor Testing.
Solid Tumor Testing Market Company Profiles
The global Solid Tumor Testing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, Agilent Technologies Inc, AMSBIO, Biocare Medical LLC, BioLifeSolutions Inc, CellGenix GmbH., Corning Inc, F. Hoffmann-La Roche AG, Illumina Inc, LGC SeraCare, MedGenome Labs Private Ltd, Myriad Genetics Inc, Princeton CryoTech, QIAGEN, Quest Diagnostics Inc, STEMCELL Technologies Inc, Thermo Fisher Scientific Inc
Recent Solid Tumor Testing Market Developments
The global Solid Tumor Testing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Solid Tumor Testing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
Genetic Testing
-Next generation sequencing
-Real-time PCR
-Fluorescent In-Situ Hybridization
-Fragment Analysis
Conventional Testing
By Application
Prostate
Breast
Colorectal
Endometrial
Lung
Melanoma
Brain
Thyroid
Liver
Ovarian
Others
By End-User
Pharmaceutical and Biotechnology Companies
Hospitals
Contract Research Organizations
Academic Research Institutions
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbott Laboratories
Agilent Technologies Inc
AMSBIO
Biocare Medical LLC
BioLifeSolutions Inc
CellGenix GmbH.
Corning Inc
F. Hoffmann-La Roche AG
Illumina Inc
LGC SeraCare
MedGenome Labs Private Ltd
Myriad Genetics Inc
Princeton CryoTech
QIAGEN
Quest Diagnostics Inc
STEMCELL Technologies Inc
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Solid Tumor Testing Market Overview and Key Findings, 2024
1.2 Solid Tumor Testing Market Size and Growth Outlook, 2021- 2030
1.3 Solid Tumor Testing Market Growth Opportunities to 2030
1.4 Key Solid Tumor Testing Market Trends and Challenges
1.4.1 Solid Tumor Testing Market Drivers and Trends
1.4.2 Solid Tumor Testing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Solid Tumor Testing Companies
2. SOLID TUMOR TESTING MARKET SIZE OUTLOOK TO 2030
2.1 Solid Tumor Testing Market Size Outlook, USD Million, 2021- 2030
2.2 Solid Tumor Testing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. SOLID TUMOR TESTING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. SOLID TUMOR TESTING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Genetic Testing
-Next generation sequencing
-Real-time PCR
-Fluorescent In-Situ Hybridization
-Fragment Analysis
Conventional Testing
By Application
Prostate
Breast
Colorectal
Endometrial
Lung
Melanoma
Brain
Thyroid
Liver
Ovarian
Others
By End-User
Pharmaceutical and Biotechnology Companies
Hospitals
Contract Research Organizations
Academic Research Institutions
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Solid Tumor Testing Market, 2025
5.2 Asia Pacific Solid Tumor Testing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Solid Tumor Testing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Solid Tumor Testing Market, 2025
5.5 Europe Solid Tumor Testing Market Size Outlook by Type, 2021- 2030
5.6 Europe Solid Tumor Testing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Solid Tumor Testing Market, 2025
5.8 North America Solid Tumor Testing Market Size Outlook by Type, 2021- 2030
5.9 North America Solid Tumor Testing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Solid Tumor Testing Market, 2025
5.11 South America Pacific Solid Tumor Testing Market Size Outlook by Type, 2021- 2030
5.12 South America Solid Tumor Testing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Solid Tumor Testing Market, 2025
5.14 Middle East Africa Solid Tumor Testing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Solid Tumor Testing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Solid Tumor Testing Market Size Outlook and Revenue Growth Forecasts
6.2 US Solid Tumor Testing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Solid Tumor Testing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Solid Tumor Testing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Solid Tumor Testing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Solid Tumor Testing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Solid Tumor Testing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Solid Tumor Testing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Solid Tumor Testing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Solid Tumor Testing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Solid Tumor Testing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Solid Tumor Testing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Solid Tumor Testing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Solid Tumor Testing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Solid Tumor Testing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Solid Tumor Testing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Solid Tumor Testing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Solid Tumor Testing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Solid Tumor Testing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Solid Tumor Testing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Solid Tumor Testing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Solid Tumor Testing Industry Drivers and Opportunities
7. SOLID TUMOR TESTING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. SOLID TUMOR TESTING COMPANY PROFILES
8.1 Profiles of Leading Solid Tumor Testing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
Agilent Technologies Inc
AMSBIO
Biocare Medical LLC
BioLifeSolutions Inc
CellGenix GmbH.
Corning Inc
F. Hoffmann-La Roche AG
Illumina Inc
LGC SeraCare
MedGenome Labs Private Ltd
Myriad Genetics Inc
Princeton CryoTech
QIAGEN
Quest Diagnostics Inc
STEMCELL Technologies Inc
Thermo Fisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Solid Tumor Testing Market Overview and Key Findings, 2024
1.2 Solid Tumor Testing Market Size and Growth Outlook, 2021- 2030
1.3 Solid Tumor Testing Market Growth Opportunities to 2030
1.4 Key Solid Tumor Testing Market Trends and Challenges
1.4.1 Solid Tumor Testing Market Drivers and Trends
1.4.2 Solid Tumor Testing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Solid Tumor Testing Companies
2. SOLID TUMOR TESTING MARKET SIZE OUTLOOK TO 2030
2.1 Solid Tumor Testing Market Size Outlook, USD Million, 2021- 2030
2.2 Solid Tumor Testing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. SOLID TUMOR TESTING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. SOLID TUMOR TESTING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Genetic Testing
-Next generation sequencing
-Real-time PCR
-Fluorescent In-Situ Hybridization
-Fragment Analysis
Conventional Testing
By Application
Prostate
Breast
Colorectal
Endometrial
Lung
Melanoma
Brain
Thyroid
Liver
Ovarian
Others
By End-User
Pharmaceutical and Biotechnology Companies
Hospitals
Contract Research Organizations
Academic Research Institutions
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Solid Tumor Testing Market, 2025
5.2 Asia Pacific Solid Tumor Testing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Solid Tumor Testing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Solid Tumor Testing Market, 2025
5.5 Europe Solid Tumor Testing Market Size Outlook by Type, 2021- 2030
5.6 Europe Solid Tumor Testing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Solid Tumor Testing Market, 2025
5.8 North America Solid Tumor Testing Market Size Outlook by Type, 2021- 2030
5.9 North America Solid Tumor Testing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Solid Tumor Testing Market, 2025
5.11 South America Pacific Solid Tumor Testing Market Size Outlook by Type, 2021- 2030
5.12 South America Solid Tumor Testing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Solid Tumor Testing Market, 2025
5.14 Middle East Africa Solid Tumor Testing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Solid Tumor Testing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Solid Tumor Testing Market Size Outlook and Revenue Growth Forecasts
6.2 US Solid Tumor Testing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Solid Tumor Testing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Solid Tumor Testing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Solid Tumor Testing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Solid Tumor Testing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Solid Tumor Testing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Solid Tumor Testing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Solid Tumor Testing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Solid Tumor Testing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Solid Tumor Testing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Solid Tumor Testing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Solid Tumor Testing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Solid Tumor Testing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Solid Tumor Testing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Solid Tumor Testing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Solid Tumor Testing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Solid Tumor Testing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Solid Tumor Testing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Solid Tumor Testing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Solid Tumor Testing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Solid Tumor Testing Industry Drivers and Opportunities
7. SOLID TUMOR TESTING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. SOLID TUMOR TESTING COMPANY PROFILES
8.1 Profiles of Leading Solid Tumor Testing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
Agilent Technologies Inc
AMSBIO
Biocare Medical LLC
BioLifeSolutions Inc
CellGenix GmbH.
Corning Inc
F. Hoffmann-La Roche AG
Illumina Inc
LGC SeraCare
MedGenome Labs Private Ltd
Myriad Genetics Inc
Princeton CryoTech
QIAGEN
Quest Diagnostics Inc
STEMCELL Technologies Inc
Thermo Fisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
